Comparison of defibrillator therapy and other therapeutic modalities for sustained ventricular tachycardia or ventricular fibrillation associated with coronary artery disease
References (36)
Implantable defibrillator therapy: does it really prolong life? How can we prove it?
Am J Cardiol
(1993)- et al.
Long-term outcome with the automatic implantable cardioverter-defibrillator
J Am Coll Cardiol
(1989) - et al.
Benefits of implantable defibrillators are overestimated by sudden death rates and better represented by the total arrhythmic death rates
J Am Coll Cardiol
(1991) - et al.
The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias
J Am Coll Cardiol
(1988) - et al.
Influence of left ventricular function on survival and mode of death after implantable defibrillator therapy (Cleveland Clinic Foundation and Montefiore Medical Center Experience)
Am J Cardiol
(1993) - et al.
Time to first shock and clinical outcome in patients receiving an automatic implantable cardioverter-defibrillator
J Am Coll Cardiol
(1989) - et al.
Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease
J Am Coll Cardiol
(1990) - et al.
The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction
Am J Cardiol
(1988) - et al.
When “sudden cardiac death” is not so sudden: lessons learned from the automatic implantable defibrillator
Am Heart J
(1988) Management of survivors of cardiac arrest: is electrophysiologic testing obsolete in the era of implantable defibrillators?
J Am Coll Cardiol
(1990)
Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmia
J Am Coll Cardiol
(1987)
Determinants of survival in patients with malignant ventricular arrhythmia associated with coronary artery disease
Am J Cardiol
(1988)
Implantable cardioverter-defibrillator therapy in survivors of out-of-hospital sudden cardiac death with inducible arrhythmias
J Am Coll Cardiol
(1993)
Survival after implantation of the cardioverter defibrillator
Am J Cardiol
(1992)
Short-term morbidity and mortality of implantation of automatic implantable cardioverter-defibrillator
J Thorac Cardiovasc Surg
(1990)
Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias
J Am Coll Cardiol
(1992)
Operative mortality with implantation of the automatic cardioverter-defibrillator
Am J Cardiol
(1991)
Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study)
Am J Cardiol
(1993)
Cited by (20)
There should never be another antiarrhythmics versus implantable defibrillator (AVID) trial
1997, American Journal of CardiologyPredictors of long-term survival in patients with malignant ventricular arrhythmias
1997, American Journal of CardiologyEvaluation of end points of serial drug testing in patients with sustained ventricular tachycardia after healing of acute myocardial infarction
1995, The American Journal of CardiologyImplantable cardioverter-defibrillators: Not the ultimate gold standard for gauging therapy of VT/fibrillation
1994, The American Journal of Cardiology
Copyright © 1994 Published by Elsevier Inc.